Presentation Evolving Concepts of Angiogram: Fractional Flow Reserve Discordances Presenter: G. Toth March 24, 2014
Presentation Early Post-discharge Bleeding and Antiplatelet Discontinuation in AMI Patients Treated with PCI Presenter: 222318|Tracy Wang February 03, 2014
Presentation TCT 2013 TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting... Presenter: Joshua Loh October 29, 2013
Presentation TCT 2013 Technology Review and Clinical Results (DISCOVER Trial) Presenter: Charles Davidson October 28, 2013
Presentation TCT 2013 DISCOVER: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis Presenter: Joachim Schofer October 28, 2013
Presentation TVT 2013 Clinical Results – The Discover Trial Presenter: Charles Davidson June 13, 2013
Presentation EuroPCR 2013 The Unplanned DAPT Discontinuation Patient: How Can I Make Informed Decisions? Presenter: Sigmund Silber May 22, 2013
Presentation EuroPCR 2013 Prospective, Multicenter Evaluation of the 18FDirectFlow TranscatheterAortic Valve: The DISCOVER Trial: Final Study Enrollment Presenter: Joachim Schofer May 22, 2013
Presentation Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES Presenter: K. Tandjung April 26, 2013
Presentation Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular A-fib Presenter: Manesh R. Patel February 03, 2013
Presentation TCT 2013 Is There Sufficient Evidence To Discourage The Use Of Multi-Vessel Angioplasty During STEMI? An Analysis of 35,008 Patients Presenter: Sayan Sen, Darrel Francis, Ricardo Petraco, Sukhjinder Nijjer, Nicolas Foin, Rodney Foale, Nearchos Hadjiloizou, Alun Hughes, Ghada Mikhail, Iqbal Malik, Justin Davies January 31, 2013
Presentation TCT 2013 Discontinuation of Long-Term Clopidogrel Therapy is Associated with Death and Myocardial Infarction after Saphenous Vein Graft Percutaneous Coronary Intervention Presenter: Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Albert Shen, Vicken Aharonian, Prakash Mansukhani, Gregg Stone, Martin Leon, Jeffrey Moses, Naing Moore, Ric Hyett, Richard Contreras, Somjot Brar January 31, 2013
Presentation Discontinuation of Long-term Clopidogrel Therapy Is Associated with Death and MI After SVG PCI Presenter: A. Sachdeva November 13, 2012
Presentation TCT 2012 Reconciling Discordance Between Echo and CT in TAVR Presenter: Robert Siegel October 25, 2012
Presentation TCT 2012 TCT-18. Long-term Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve After Deferral of Percutaneous Coronary Intervention Presenter: Tim van de Hoef October 23, 2012
Presentation TCT 2012 TCT-55. Major Adverse Cardiac Events Associated with Discontinuation of Clopidogrel Treatment Within the First Year After Coronary Stent Implantation in Western Denmark Presenter: Michael Maeng October 23, 2012
Presentation RESET Trial: A New Strategy for Discontinuation of Dual Antiplatelet Therapy Presenter: B-K Kim September 19, 2012
Presentation Clopidogrel Discontinuation After Myocardial Infarction and Risk of Thrombosis Presenter: Mette Charlot July 19, 2012
Presentation Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel in Stable CAD Patients Presenter: Matthew J. Price June 13, 2012